This category includes articles about social entrepreneurs, typically about businesses with a for-profit model with a social mission embedded into the fabric of the business.
This category includes articles about social entrepreneurs, typically about businesses with a for-profit model with a social mission embedded into the fabric of the business.
Recognition is the latest example of ongoing praise and international attention for the new $45 million facility for aspiring entrepreneurs
Press Release – Feb. 24, 2017 – Scan the world from Norway to China and you won’t find a new university building much better than Lassonde Studios at the University of Utah, according to Architectural Digest, a premier publication for architecture news and trends. In a new report, the publication identifies Lassonde Studios as one of the nine best new university buildings around the globe.
“One of the first design elements guests of the University of Utah’s Lassonde Studios will notice is an all-copper façade,” Architectural Digest reported. “The $45 million project by Yazdani Studio of Cannon Design in association with EDA Architects opened in August 2016, and its copper exterior is made to fade and change color as it ages. … The structure is built on a grid system, which will allow rooms to be easily reconfigured as demands for the space fluctuate.”
The recognition is the latest in a wide variety of international praise and attention for Lassonde Studios. All students on campus are invited to live, create and launch new companies here. The building houses 400 residents above a 20,000-square-feet innovation space on the first floor that is open to all students on campus.
Lassonde Studios is managed by the Lassonde Entrepreneur Institute, an interdisciplinary division of the David Eccles School of Business that was recently ranked as the No. 1 program in the nation for aspiring entrepreneurs by LendEDU and the No. 15 graduate and No. 18 undergraduate program for entrepreneurs in the nation by the Princeton Review. Together, the Lassonde Institute and the Eccles School offer many programs, degrees and scholarships for students interested in entrepreneurship.
“We had a great team with a vision to accomplish Pierre Lassonde’s goal to build an iconic structure that would enhance the experience of our students and create more entrepreneurs,” said Troy D’Ambrosio, executive director of the Lassonde Institute and an assistant dean at the David Eccles School of Business. “It’s great to see his dream being recognized.”
Architectural Digest acknowledged Lassonde Studios alongside buildings in the United States, Norway and China. These buildings function as everything from classrooms and technology centers to student unions and dorms.
“Just as education around the world continues to evolve and innovate, so do the campuses that house the brightest future artists, scholars and financiers,” Architectural Digest reported. “These new structures make the grade for state-of-the-art technology, adherence to historic detailing and architecturally significant design.”
International attention for Lassonde Students began as soon as the project was announced. Months before the groundbreaking in October 2014, for example, Bloomberg Businessweek published an article titled “University of Utah’s New Dorm Mimics Google Headquarters.” In the article, the publication reported: “In a move it hopes will lure budding entrepreneurs who dream of souped-up Silicon Valley workspaces, the University of Utah plans to build a residence hall that blurs life and work the same way technology giants Facebook and Google do at their headquarters.”
In a more recent article from August 2016, The New York Times featured Lassonde Studios in a story about how “universities are investing in big, high-tech buildings in the hope of evoking big, high-tech thinking.” The New York Times reported: “The residential component has been absorbed into this live-work building, anticipating the early lifestyle of dot-com employees, whose living quarters usually resemble walk-in closets. The Utah version is more plush, however.”
Other notable attention includes articles by Fast Company, Inc. Magazine, The Associated Press, ArchDaily and many construction trade publications.
On top of attention from journalists and news agencies, Lassonde Studios received an award as the most outstanding public building over $10 million from Utah Construction & Design in 2016 and an “Award of Excellence” from the Associated General Contractors of Utah. Lassonde Studios is also a finalist for the South by Southwest Education (SXSWedu) Learn by Design Awards.
Learn more about Lassonde Studios and take a virtual tour at lassonde.utah.edu/studios.
About the Lassonde Entrepreneur Institute
The Lassonde Entrepreneur Institute is a nationally ranked hub for student entrepreneurship and innovation at the University of Utah and an interdisciplinary division of the David Eccles School of Business. The first programs were offered in 2001, through the vision and support of Pierre Lassonde, an alumnus of the Eccles School and successful mining entrepreneur. The institute now provides opportunities for thousands of students to learn about entrepreneurship and innovation. Programs include workshops, networking events, business-plan competitions, startup support, innovation programs, graduate seminars, scholarships, community outreach and more. All programs are open to students from any academic major or background. The Lassonde Institute also manages the Lassonde Studios, a new $45 million innovation space and housing facility for all students. Learn more at lassonde.utah.edu.
Funds on-lent to 11 microfinance institutions and off-grid solar companies operating in Latin America (Ecuador, Guatemala, Nicaragua), Africa (Kenya, Rwanda, Tanzania), and Asia (India, Kazakhstan, Mongolia)
Press Release – February 28, 2017 — Veteran U.S. social impact investment manager, Developing World Markets (DWM), has invested $60.8 million in 11 businesses promoting renewable energy and climate solutions across Latin America, Africa and Asia. Anchor investors in DWM’s ORCA (Off-Grid, Renewable and Climate Action) Impact Note include two faith-based pension funds, The Church Pension Fund and Wespath Benefits and Investments, with each contributing $30 million. Developing World Markets structured the transactions; the investees include off-grid solar operating companies, D.light, Kingo Energy, and Off-Grid Electric, as well as microfinance institutions Saija Finance, Satin Creditcare Network, KMF (Kazakhstan), XacBank, FDL (Nicaragua), Produbanco (Ecuador), Banco Procredit (Ecuador), and FINCA Nicaragua. Invested funds are earmarked for solar home solutions and other forms of renewable energy, as well as CO2 and greenhouse gas mitigation activities. DWM estimates the funding will enable some 200,000 families to access solar home solutions. Worldwide more than 2.2 billion people live without reliable access to electricity.
“The companies financed by the ORCA Note are employing innovative, market-based mechanisms to solve critical development needs. For the equivalent price of what was previously spent on outdated energy sources such as kerosene, low-income individuals in developing countries can access clean, modern renewable energy technology for their homes and families; addressing not only energy, but health issues as well,” said Peter Johnson, Managing Partner of Developing World Markets. “DWM is honoured to support these pioneering organizations, and we are in turn grateful for the support of our investors.”
The ORCA Impact Note is U.S. dollar denominated with a coupon of 5.85%. Its four year term will run through December 27, 2020. The structuring of the Note was unique in its transparency, as borrowers were pre-identified and noteholders were certain of where and how the proceeds would be used, prior to investment. Since its founding in 1994, DWM has structured and invested over $1 billion into more than 170 companies across more than 50 developing countries.
“The Church Pension Fund was pleased to serve as an anchor investor, which helped bring other investors to the table to provide renewable energy finance loans to social businesses in the developing world. This investment will impact the lives of people on three different continents and is reflective of our commitment to earning a competitive rate of return. We look forward to building our relationship with Developing World Markets as we continue to explore future SRI opportunities,” said Roger Sayler, Managing Director and Chief Investment Officer of The Church Pension Fund.
“Wespath was pleased to commit to the DWM ORCA Impact Note, an investment that focuses on providing critical energy access in the developing world,” said Dave Zellner, Chief Investment Officer of Wespath Benefits and Investments. “This impact investment, which continues a more than decade-long relationship with DWM, reflects the intent that our global investment activities have a positive impact on society and the environment while earning a market rate of return.”
Additional investors in the Note include King & Shaxson (London), Invethos (Switzerland) and Developing World Markets (United States). Law firms McGuire Woods, LLP in the United States and Arendt & Medernach in Luxembourg advised on the transaction.
About Developing World Markets
Developing World Markets (DWM) is an emerging and frontier markets focused, impact investment firm. DWM seeks investments that provide risk-appropriate returns and measurable social or environmental benefits. Since its founding in 1994, DWM has structured and invested over $1 billion into more than 170 companies across more than 50 developing countries. The firm is headquartered in Stamford, CT, USA. For more information visit: www.dwmarkets.com.
About Wespath Benefits and Investments
Wespath Benefits and Investments (Wespath) is a general agency of The United Methodist Church with fiduciary responsibility for the benefit plans it administers and the assets it invests.
Wespath supports benefit plans for more than 100,000 participants around the world, and investments for more than 100 United Methodist-affiliated endowments, foundations and other institutions. Wespath manages approximately $21 billion in assets, proactively incorporating environmental, social and governance factors. Our activities reflect the stated values of the Church and help strengthen financial sustainability across all investments, consistent with our fiduciary obligation to all.
Wespath is the largest reporting faith-based pension fund in the world, and among the top 100 pension funds in the United States. As a sustainable investor, Wespath is committed to active ownership through corporate and public policy engagement, proxy voting and the management of excessive sustainability risk. Wespath’s sustainable investment activities are carried out by Wespath Investment Management, the agency’s investments division. Learn more at www.wespath.org.
About The Church Pension Fund
The Church Pension Fund (CPF) is an independent financial services organization that serves the Episcopal Church. With approximately $12 billion in assets, CPF and its affiliated companies, collectively the Church Pension Group (CPG), provide retirement, health, and life insurance benefits to clergy and lay employees of the Episcopal Church. CPG also offers property and casualty insurance as well as book and music publishing, including the official worship materials of the Episcopal Church. Learn more at www.cpg.org.
Press Release – March 01, 2017 09:00 AM Eastern Standard Time – RADNOR, Pa. — Hartford Funds today announced that it has launched the Hartford Global Impact Fund (A-share: HGXAX). Sub-advised by Wellington Management, the Hartford Global Impact Fund will seek long-term capital appreciation by investing in companies that focus their operations in areas that the Fund believes are likely to address the world’s major social and environmental challenges.
The Fund invests in companies that the sub-adviser believes are likely to address major social and environmental challenges including, but not limited to, health, clean water and sanitation, financial inclusion, alternative energy, and resource efficiency, as determined by Wellington.
“We’re delighted to expand our socially responsible investment solutions for investors who want to align their portfolios with their values,” said Anita Baldwin, Managing Director and Head of Research for Hartford Funds.
The Hartford Global Impact Fund complements Hartford Funds’ existing socially responsible investing solution, the Hartford Environmental Opportunities Fund (HEOMX). Launched in February 2016, the Environmental Opportunities Fund seeks long-term capital appreciation by identifying companies it believes represent attractive investments and also address environmental challenges and/or seeks to improve the efficiency of resource consumption.
“The design and launch of the Hartford Global Impact Fund aligns with our human-centric investing philosophy and is a direct response to increasing advisor and investor demand for more products that take ESG factors into consideration,” Baldwin added.
Wellington Management’s Eric Rice, PhD., Managing Director and Portfolio Manager, and Patrick Kent, CFA, CMT, Managing Director and Portfolio Manager, will manage the Hartford Global Impact Fund.
About Hartford Funds
Founded in 1996, Hartford Funds is a leading provider of mutual funds and 529 college savings plans. Using its human-centric investing approach, Hartford Funds creates strategies and tools designed to address the needs and wants of investors. Leveraging partnerships with leading practice management experts, Hartford Funds delivers insight into the latest demographic trends and investor behavior.
As of October 24, 2016, the firm’s line-up includes more than 55 mutual funds in a variety of styles and asset classes, and five strategic beta ETFs. Its mutual funds (with the exception of certain fund of funds) are sub-advised by Wellington Management or Schroder Investment Management North America Inc. The strategic beta ETFs offered by Hartford Funds are designed to help address investors’ evolving needs by leveraging a unique risk-optimized approach, which identifies risks within each asset class and then deliberately and systematically re-allocates capital toward risks more likely to enhance return potential. Hartford Funds has mutual fund assets under management of $81.5 billion as of December 31, 2016 (excluding assets used in certain annuity products). For more information about our investment family, visit www.hartfordfunds.com.
All investments are subject to risk, including the possible loss of principal. There is no guarantee the Fund will achieve its stated objective. The Fund’s share price may fluctuate due to market risk and/or security selections that may underperform the market or relevant benchmarks. Foreign investments can be riskier and more volatile than U.S. investments due to the adverse effects of currency exchange rates, differences in market structure and liquidity, as well as political and economic developments in foreign countries and regions (e.g., “Brexit”). These risks are generally greater for investments in emerging markets. Small-cap securities can have greater risk and volatility than large-cap securities. Investing in companies that seek to address major social and environmental challenges may cause the Fund to forego certain investment opportunities and underperform Funds that do not have a similar focus. By investing in cash and money market investments, the Fund may lose the benefit of market upswings. Because it invests in a master portfolio, the Fund is also subject to the risks related to a master-feeder structure.
Hartford Funds refers to Hartford Funds Management Group, Inc., and its subsidiaries, including the mutual funds’ investment manager, Hartford Funds Management Company, LLC (HFMC), the mutual funds’ distributor, Hartford Funds Distributors, LLC, Member FINRA, as well as Lattice Strategies LLC, a wholly owned subsidiary of HFMC, which serves as the adviser to exchange-traded funds (ETFs). Certain funds are sub-advised by Wellington Management Company LLP or Schroder Investment Management North America Inc. Schroder Investment Management North America Ltd. serves as a secondary sub-adviser to certain funds. ETFs are distributed by ALPS Distributors, Inc. (ALPS). Hartford Funds is not affiliated with any fund sub-adviser or ALPS. The MIT AgeLab is not an affiliate or subsidiary of Hartford Funds.
Investors should carefully consider the investment objectives, risks, charges, and expenses of a fund before investing. This and other information can be found in the fund’s prospectus, which should be read carefully before investing. To obtain a mutual fund prospectus or summary prospectus, please call 888-843-7824 (retail) or 800-279-1541 (institutional); ETF prospectuses can be obtained by calling 415-315-6600.
“The Hartford” is The Hartford Financial Services Group Inc. (“HFSG”) and its subsidiaries. HFD is a subsidiary of The HFSG.
Some of the statements in this release may be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. We caution investors that these forward-looking statements are not guarantees of future performance, and actual results may differ materially. Investors should consider the important risks and uncertainties that may cause actual results to differ. These important risks and uncertainties include those discussed in The Hartford’s Quarterly Reports on Form 10-Q, our 2015 Annual Report on Form 10-K and the other filings The Hartford makes with the Securities and Exchange Commission. We assume no obligation to update this release, which speaks as of the date issued.
From time to time, The Hartford may use its website to disseminate material company information. Financial and other important information regarding The Hartford is routinely accessible through and posted on our website at http://ir.thehartford.com. In addition, you may automatically receive email alerts and other information about The Hartford when you enroll your email address by visiting the “Email Alerts” section at http://ir.thehartford.com.
Press Release – AUSTIN — Freedom Solar, the leader in turnkey solar installations in Texas, has announced a substantial new incentive for homeowners serviced in rural electric cooperatives (outside of Austin and San Antonio) to install solar on their homes.
Freedom Solar is offering qualifying homeowners an up-front rebate of 15 cents per watt, up to $3,000. A qualifying homeowner is anyone who lives in a utility territory that does not currently offer a rebate for solar.
“Our commitment as a company is to increase solar adoption across all areas of Texas, especially to the 75 rural electric cooperatives that serve more than 3 million residents but do not offer any economic incentives for solar generation,” says Kyle Frazier, director of sales.
The discount represents the value of renewable energy credits generated by the residential solar system, which Freedom Solar will purchase from the customer and retire as part of the company’s commitment to building a more sustainable future for generations to come.
Freedom Solar started utilizing the policy of purchasing renewable energy credits to offset the carbon footprint associated with its operations last year, and hopes to become entirely carbon-neutral by 2018.
Bret Biggart, managing director, says: “Over the past decade we’ve seen solar prices decrease and solar efficiency increase dramatically; however, the upfront cost of solar installations often makes it impossible for rural Texas residents to transition to renewable energy because they don’t have access to the same substantial solar rebates offered by municipal city utilities. We’ve introduced this new program to change that and make solar accessible to all Texans.”
Freedom Solar’s innovative rural rebate program is made possible by their partnership with SunPower as a master dealer, the only company with that distinction in Texas.
Freedom Solar will be able to provide 40 homeowners with this incentive to per quarter, for a total of 160 budgeted per year.
“For us, the best part of solar energy is that doing the right thing environmentally is also the right thing to do financially. This program is a small part of our efforts to help build a more economically and environmentally sustainable future for Texas and one more step towards making that dream a reality,” says Frazier.
For more information, visit http://www.freedomsolarpower.com/.
Salt Lake City, Utah and Albuquerque, New Mexico, January 23rd, 2017/PRBuzz: BREAKTHROUGH PATENTED AND PATENT PENDING EARLY STAGE TECHNOLOGIES ARE DESIGNED TO DETECT EARLY TUMORS VIA FAINT BIOELECTRIC SIGNALS AND READ HOW A TUMOR IS COMMUNICATING WITH ITSELF AND DELIVERS A CUSTOMIZED BIOELECTRIC SIGNAL TO JAM CELL DIVISION AND BLOOD SUPPLY TO THE TUMOR, THUS DESTROYING THE CANCER TUMOR, FOLLOWED THEREAFTER BY A FULL SEQUENCE OF ORGAN REGENERATION BIOELECTRIC SIGNALS INCLUDING STEM CELL HOMING AND DIFFERENTIATION. IT IS HOPED BY THE INVENTORS THAT BIOELECTRIC SIGNALING TREATMENTS WILL BE LESS TOXIC THAN CHEMO OR RADIATION.
Collaboration will draw upon Leonhardt’s leading position in bioelectric stimulation controlled protein expression and Neuro Tech Holdings premier customized bioelectric read and write neuro code tumor treatment platform
CancerCell, a Leonhardt Ventures’ startup – see video – https://vimeo.com/178690394 – incubating in the Leonhardt’s Launchpads Utah, Inc. innovation accelerator, a private licensable technology platform and team developing personalized bioelectric cancer therapies, announced today that it will enter into a worldwide strategic collaboration with Neuro CodeTech Holdings to develop, manufacture and commercialize novel bioelectric based, individualized bioelectric cancer therapies. The collaboration will combine Leonhardt’s leading bioelectric stimulation controlled protein expression portfolio and research program with Neuro Code Tech Holdings proprietary cancer neuro-code read and write technology platform, providing personalized medicine solution to shrinking cancer tumors, by stopping cell division, and starving them of blood supply. Together, the two companies will develop individually tailored cancer therapies against a broad range of cancers to potentially provide a new treatment paradigm for cancer patients.
The collaboration will focus on the development of bioelectric cancer tumor destruction therapies targeting the inactivation of a tumor’s ability to continue cell division based upon both Leonhardt’s and Neuro Code Tech Holdings individualized cancer therapy clinical platforms for the potential treatment of multiple cancers. With Neuro Tech Holdings patented technology a patient’s cancer tumor’s communication signals can be rapidly read utilizing next generation neural code reading technology to define a spectrum of unique mutation promoting signals that can be jammed and thus prevented from further cell division by a customized bioeleletric return signal. The Leonhardt bioelectric signal controlled protein expression technology can be used to activate release of a mRNA encoding selected neoepitope which can be manufactured for each individual tumor’s mutanome signature by a specific bioelectric signal, which can trigger an immune response highly specific to the tumor resulting in precisely targeted cancer cell death. The Leonhardt patented and patent pending technology platform includes signals for stopping cell division and halting blood supply to destroy a cancer tumor followed by over thirteen organ regeneration promoting signals and protein expressions to rebuild the organ after the cancer has been eliminated.
Initial clinical development will focus on combination studies targeted at shrinking brain, pancreas and breast cancer tumors. Under the terms of the agreement Leonhardt will pay Neuro Code Tech Holdings in installment payments as near-term and long-term milestones are met and the two companies will share ownership of the startups that receive exclusive licenses to commercialize the combined technologies.
The specific Neuro Code Tech Holdings LLC intellectual property to be utilized in this agreement includes U.S. patent 9,032,964, entitled “Method and system for processing cancer cell electrical signals for medical therapy.” According to the abstract, a scientific computer system with processor capable of recording, storing, and reprogramming the natural electrical signals of cancer cells as found in tumors of humans and animals. The reprogramming process is designed to create a confounding electrical signal for retransmission into a malignant tumor to damage or shut-down the cellular internal electrical communication system. Altering the electrical charge on the glycocalyx of the outer cell membrane is also part of the treatment by application of ions. The invention causes cancer cell death as a medical treatment using ultra-low voltage and amperage encoded signals which are reprogrammed from cancer cell communication signals.
Dr. Santosh Kesari, Neuro Scientist and Chief Scientific Advisor to CancerCell and CerebraCell, Leonhardt Ventures cos. commented: “We are delighted to collaborate with leading bioelectric personalized cancer therapy inventors such as Eleanor Schuler of Neuro Code Tech Holdings. Supported by its extensive bioelectric stimulation signal protein expression control understanding, the Leonhardt team has been building experience with its proprietary bioelectric driven therapies, often combined with stem cell based compositions, in a number of organ specific applications over nearly three decades. Combining Leonhardt’s broad proprietary capabilities in the design, formulation, manufacturing and clinical testing of combination therapy organ regeneration and controlled protein expression technologies with Neuro Code Tech Holdings’ eminent neural code read and write signaling expertise, will allow us, on a global scale, to drive forward the development of individualized therapies to market to not only treat and potentially stop a broad range of cancers but also to fully regenerate those same organs post cancer. No other research group we know of is offering this one two punch combination designed to help patients recover to a full quality of life.” Dr. Kesari is Chair and Professor, Department of Translational Neurosciences and Neurotherapeutics, Director, Neuro-oncology the Providence John Wayne Cancer Institute and Director of Neuro-Oncology at the Pacific Neuroscience Institute and Brain Tumor Center both in Santa Monica, California where CancerCell and CerebraCell expect to launch first-in-man clinical trials in the future – http://www.pacificneuroscienceinstitute.org/
Eleanor Schuler, CSO of Neuro Code Tech Holdings LLC added: “This alliance underpins Neuro Code Tech Holding’s strategy of collaborating with companies that are committed to developing truly disruptive therapies and its long term ambitions of bringing its patented inventions to clinics to begin helping people recover from the devastation of cancer. Our proprietary patented technology is the only one we know of that reads the communication signals within a tumor and customizes back an individualized therapy. No two cancer tumors are alike. To treat them you need a customized approach.”
“Unlike any medicine ever developed, virtually all cancer patients may potentially benefit from a custom built bioelectric cancer therapy followed by total organ regeneration,” said Luis Ortiz, Patent Counsel and President of Neuro Code Tech Holdings. “By collaborating with the Leonhardt team on this cutting edge approach, we hope to truly advance cancer treatments by using a common sense approach that is uniquely tailored to an individual patient. The Leonhardt team has a record of bringing breakthrough innovations from concept to market and strong leadership, and we believe with confidence they will do it again with this product.”
“In our work to discover the right bioelectric signals to promote organ regeneration we worked to find protein expressions that promoted cell division on demand and increased blood supply. By serendipity un-intentionally we discovered specific bioelectric signals that immediately halted cell division and halted blood supply. We sent these results into the U.S. patent office to make our first claims for a cancer therapy. In the process of filing our patents we came across the work of the Neuro Code Tech Holdings team led by Eleanor Schuler and found their technology to go a step further in having both a read and write neuro code customization. We are in awe of their inventive genius and feel honored to now be teamed with them,” stated Dr. Jorge Genovese and Howard Leonhardt co-inventors of the Leonhardt Ventures technology platform.
Link to previous related press release:
Leonhardt Ventures and CerebraCell File Patent Application for Treating Cancer Tumors with Bioelectric Stimulation –
The Leonhardt team is also working on bioelectric neuro code signal reading that it believes can be an early detection system for cancers and organ regeneration to follow cancer tumor destruction.
About Leonhardt Ventures:
Leonhardt Ventures founded in 1982 is a leading developer of organ regeneration, support assist and repair technologies. In the 1980’s the Leonhardt team led the development of predictably compliant cardiovascular balloon catheters, in the 1990’s world leadership in patented stent grafts for aneurysm repair and percutaneous heart valves, in the 2000’s Leonhardt has led the way in stem cell and bioelelectric based organ regeneration technologies. The team led the first-in-man non-surgical stem cell repair of a human heart in 2001. Leonhardt Ventures operates innovation/startup accelerators in California and Utah under the name Leonhardt’s Launchpads currently incubating 30 startups and licensable technology platforms. Leonhardt’s Launchpads and it’s startups are supported by over 37 Scientific Advisory Board members http://calxstars.com/scientific-advisory-board/ and 70+ business mentors http://calxstars.com/team-cal-x/ – Main web site: www.leonhardtventures.com
About Neuro Code Tech Holdings LLC:
Neuro Code Tech Holdings (NCTH) is a New Mexico-based company focused on the research, development and intellectual property protection of biolectronic cancer treatment technology. It’s chief scientific officer, Eleanor Schuler, has almost three decades of experience in developing and testing neuro-coded electric signals for providing a diverse spectrum of treatments for human and animal applications.
Corporate Notes: Leonhardt Ventures is Leonhardt Vineyards LLC DBA Leonhardt Ventures a Los Angeles, California LLC (formed in 1982 as sole propreitorship HJ Leonhardt & Co in Minneapolis. and converted to a California LLC in 2005). Leonhardt’s Launchpads is Cal-X Stars Business Accelerator, Inc. DBA Leonhardt’s Launchpads a California C Corporation formed in 2013. Leonhardt’s Launchpads Utah, Inc. is a Utah C corporation formed in November 2015 and officially incorporated in 2016.
Caution Statement: Technologies referenced herein are early stage developments in early feasibility bench top and animal testing phase. Safety and efficacy is not yet proven. No efficacy or safety claims are implied. For potential investors investing in our innovation accelerator or its startups/licensable technology platforms is very high risk due to the early stage of these developments, the high regulatory and development cost to bring products of this type to market, patent lititagion risk, heavy competition and our limited capital on hand and small staff. This type of investment is not suitable to most and is limited in access at this time only to sophisticated accredited investors only with direct long standing experience in these type of investments. Due our small staff and many developments in process not all of our 30+ web sites are up to date and thus information at times may be outdated. If you have any specific questions please email us at firstname.lastname@example.org
Press Release – Santa Monica, California and Salt Lake City, Utah (PR Buzz) — February 20th, 2017 – Leonhardt Ventures a leading developer of breakthrough organ regeneration and support assist technologies today announced that Dr. Leslie Miller their Chief Medical Officer will present at the 20th Annual Cardiovascular Research Technologies (CRT) Conference on Tuesday, February 21st, 2017 at 7:40 a.m. EST and 11:40am EST in the CRT CARDIOVASCULAR INNOVATIONS Showcase – see https://www.eventscribe.com/2017/CRT/aaSpeakerBios.asp
2/21/2017 7:40 AM – 7:48 AM BioLeonhardt Heart Regeneration –
2/21/2017 11:40 AM – 11:46 AM Valvublator Heart Valve Decalcification & Regeneration
Dr. Miller will be highlighting our BioLeonhardt combination bioelectric stimulator + re-fillable micro infusion pump + fifteen component stem cell based composition for heart regeneration. He will also present our Valvublator catheter based technology for decalcifying then regenerating heart valves so patients can keep their own instead of getting an implant – click here https://vimeo.com/174622660 to see Valvublator animation video . He will also show briefly our Second Heart Assist, Inc. technology which complements our BioLeonheart heart regeneration treatment by providing circulatory assist support in the descending aorta – click here to see animation video – https://vimeo.com/183574529
The BioLeonhardt bioelectric stimulator is designed to release of SDF-1 (stem cell homing), IGF-1, HGF (designed to protect against arrthymia risk), EGF, PDGF, VEGF, eNOS, Activin A+B, Follistatin and Tropoelastin as well as controlling on demand stem cell proliferation and differentiation into beating heart muscle within scar tissue. The fifteen- component heart regeneration composition includes adipose derived cells or bone marrow MSCs, muscle derived stem cells, EPCs, a full cocktail of growth factors, nutrient hydrogel, selected exosomes, selected alkaloids, selected anti-inflammatory agents, cardiac matrix and selected MicroRNAs. Click here to see BioLeonhardt animation video – https://vimeo.com/170229378
ABOUT LEONHARDT VENTURES:
Based in Santa Monica, California Leonhardt Ventures is a leading developer of cardiovascular and organ regeneration, support assist and repair technologies. Our products are designed to regenerate your own organs with a combination of bioelectric stimulation controlled release of 13+ regeneration promoting proteins and repeat delivery via a re-fillable micro infusion pump of a fifteen-component organ regeneration composition. Leonhardt Ventures founded in 1982 led the development of cardiovascular balloon catheters in the 1980s, percutaneous heart valves and stent grafts in the 1990s, cardiovascular genetic tests and organ regeneration technologies in the 2000’s. The team led first-in-man cases for percutaneous aortic aneurysm repair in 1995 and first non-surgical stem cell repair of a human heart in 2001. For additional information please visit: www.leonhardtventures.com
BioLeonhardt is focused on the development of a combination implantable bioelectric stimulator + micro infusion pump + multi-component stem cell + growth factor based composition for regenerating damaged hearts. The company is currently completing animal studies at the University of Utah funded by a USTAR Technology Acceleration Grant. See www.bioleonhardt.com
Valvublator is focused on developing a catheter based device to decalcify and regenerate damaged heart valves. See – http://leonhardtventures.com/valvublator/
ABOUT LEONHARDT’S LAUNCHPADS:
Leonhardt’s Launchpads founded in 2007 is an innovation accelerator founded by Leonhardt Ventures to accelerate the early stage development of startups emanating from its own inventions with a primary focus on organ regeneration and associated supporting technologies. Leonhardt’s Launchpads operates out of locations in Santa Monica and Pasadena, California with Cal-X Stars Business Accelerator, Inc. and in Petaluma, California in association with the University of Northern California Science and Technology Innovation Center (UNC STIC) – http://www.uncm.edu/About_BoardDirectors.php. In November of 2015 they founded Leonhardt’s Launchpads Utah, Inc. in Salt Lake City, Utah to work more closely with University of Utah researchers and other local collaborators. See – http://leonhardtventures.com/leonhardts-launchpads-utah/
CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium – http://www.crtmeeting.org/. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.
This release contains forward-looking statements, including statements regarding development of Leonhardt’s Launchpads and Leonhardt Ventures existing and new products, the Company’s progress toward commercial growth, and future opportunities and expected regulatory approvals. The Company’s actual results may differ materially from those anticipated in these forward-looking statements based upon a number of factors, including uncertainties associated with development, testing and related regulatory approvals, including the potential for future losses, complex manufacturing, high quality requirements, dependence on limited sources of supply, competition, technological change, government regulation, litigation matters, future capital needs and uncertainty of additional financing, and other risks and challenges detailed in the Company’s filings. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this release. Leonhardt’s Launchpads operates with a very small staff and limited budget while launching more than 30 startups. Not all web sites and information is able to be kept up to date all the time. If you have any specific questions about accuracy or up to date information please email us with your questions. Leonhardt’s Launchpads technologies (licensable technology platorms – startups) are very early stage and un-proven and thus are deemed very high risk investments not suitable to most. Investing in Cal-X Stars Business Accelerator, Inc. DBA Leonhardt’s Launchpads is limited to verified accredited and sophisticated investors only at this time. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.
Press Release – Washington DC | February 23, 2017: Bunker Labs DC, a 501(c)3 organization committed to veteran entrepreneurship, will host The Muster DC on February 23, 2017, to showcase and empower local veteran entrepreneurs. The experience, part of the Muster Across America Tour sponsored by JPMorgan Chase & Co., is designed to connect veterans in business, empower the Washington D.C. entrepreneurial ecosystem, and foster growth, knowledge, and success.
The event will feature expert talks and panel discussions, a pitch stage where veteran entrepreneurs can compete for the title of “top startup,” and a post-event networking reception.
Bunker Labs DC Executive Director Emily McMahan remarked, “We know this experience will be a great opportunity to gather our local veteran entrepreneur community for one day to connect and share their ideas, experiences, and to also showcase Bunker Labs DC as a great resource.”
Following World War II, roughly 50 percent of returning veterans started a business. Today, approximately 25 percent of post-9/11 veterans state they want to start a business, yet veterans own less than 10 percent of small businesses. Veterans in the Washington D.C. region interested in starting or growing small businesses have access to resources, programs, and curriculum at Bunker Labs DC that is designed to translate military experience into starting sustainable and scalable businesses.
In partnership with JPMorgan Chase, the Muster Builds America Tour will travel to 14 cities across the country to showcase veteran entrepreneurs, empower local entrepreneurial ecosystems with large-scale events, and serve as the launching point for local Bunker Labs chapters. For more information on The Muster DC, and to reserve tickets, please visit: https://nvite.com/MusterDC/f342
About Bunker Labs:
Bunker Labs is a national not-for-profit organization built by military veteran entrepreneurs to empower other military veterans as leaders in innovation. Through local chapters organized in 13 different cities, Bunker Labs provides educational programming, mentors, events, and thriving local networks to help military veterans start and grow businesses. Bunker Labs works to inspire, educate, and connect veterans with the right people and the right resources to be successful as entrepreneurs and as innovators. For more information, please visit bunkerlabs.org, follow us on Twitter @TheBunkerLabs, or like us on Facebook.
About JPMorgan Chase & Co.
JPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $2.5 trillion and operations worldwide. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management. By focusing on employment, small business and strategic initiatives as well as talent acquisition and development, JPMorgan Chase aims to position military members, veterans and their families for success in their post-service lives. To learn more about the company’s efforts, visit JPMorganChase.com/Veterans.
The Environment and Climate Change are Key Areas of Focus as Most Mission-Related Investors (Often Called Impact Investors) Intend to Increase These Allocations
Press Release – BOSTON, MA–(Marketwired – February 15, 2017) – Mission-related investing, which includes impact investing and environmental, social and governance (ESG) investing, is gaining significant momentum among non-profit institutional investors, according to a survey by global investment firm Cambridge Associates. The most common thematic focus among impact investors is the environment and climate change, with healthcare, housing, job creation, and education also cited as areas of interest by respondents in Mission-Related Investing: Current Practices and Views of Non-Profit Investors.
In a survey of 159 non-profit institutional investors around the globe, 31% say they’re currently engaged in mission-related investing — making investments designed to align with or advance institutional goals or values as well as provide financial returns. Of that group, 44% say they have increased their mission-related allocation over recent years, and 62% expect to grow their mission-related allocation in the coming five years. None of the institutions that currently make mission-related investments expect to decrease their allocations.
“This data confirms what we have observed among our clients over the past decade — that mission and impact investing has gained significant traction, and that many of our mission-focused clients view it as a core investment discipline with plans to deepen their commitment over time,” says Jessica Matthews, Managing Director at Cambridge Associates and head of the firm’s Mission-Related Investing Practice, which works with institutions to design and implement their mission related investing programs.
The respondents to the survey, fielded in 2016, include foundations, colleges and universities, religious institutions and pensions around the world, including in the United States, Italy, Japan, New Zealand, Switzerland and the UK.
Growth in Mission-Related Investing Driven Largely by Environmental and Climate Change Concerns
Overall, about three-quarters (74%) of nonprofit mission-related investors expect to increase investments to ESG and climate change-related investment strategies. Cambridge Associates found that more than three-quarters (76%) of colleges and universities that make mission-related investments either currently consider climate risk when making investment decisions (41%) or anticipate doing so in the future (35%). Among foundations, 30% already consider climate risks, and 30% anticipate doing so going forward.
Among MRI strategies, the largest portion of investors reported employing negative screens; however, the survey found that investors anticipate proactively seeking ESG and environment/climate change opportunities more so than negative screening going forward.
Challenges and Opportunities for Implementing Mission-Related Investing Strategies
Non-profit mission-related investors say the biggest challenge in implementing their strategies is a lack of adequate mission-related investment options, followed by their own resource constraints.
“The good news for mission-related investors is that we’re seeing a proliferation of ESG and impact investing strategies coming to market, so this product supply problem is becoming less of a barrier to entry over time,” says Matthews. “Across asset classes, we track over 1,000 MRI funds in our manager databases, and that number has steadily increased since we started tracking the data in 2008. That said, manager diligence and selection is increasingly important in this space just as it is within any other investment strategy.”
Matthews adds that an appropriate and well-constructed governance model — including setting a well-defined investment policy — can add to the success of an impact or mission-related investment program. “Institutions can lay the groundwork today that will help them arrive at better investing decisions in the future, regarding both risks and opportunities across the entire portfolio,” she says.
“Colleges, universities, foundations and family offices are increasingly paving the way in implementing thoughtful mission-related investing programs,” she adds. “Investors are truly starting to recognize that social and environmental goals can be effectively integrated alongside their investment objectives.”
For additional information and insights into the mission and origins of the Mission-Related Investing practice at Cambridge Associates, read an exclusive panelist Q&A featuring Jessica Matthews on The Economist’s Impact Investing blog. Matthews is participating in a discussion titled “Seeking Impact: The Measurement Challenge” at today’s The Economist’s Impact Investing Conference in New York.
About Cambridge Associates
Cambridge Associates is a global investment firm founded in 1973 that builds customized investment portfolios for institutional investors and private clients around the world. Working alongside its early clients, among them several leading universities, the firm pioneered the strategy of high equity orientation and broad diversification, which since the 1980s has been a primary driver of performance for these leading fiduciary investors. Cambridge Associates serves over 1,100 global investors — primarily foundations and endowments, pensions and family offices — and delivers a range of services, including outsourced investment (OCIO) solutions, traditional advisory services, and access to research and tools across global asset classes. Cambridge Associates has more than 1,300 employees — including over 150 research staff — serving its client base globally. The firm maintains offices in Arlington, VA; Boston; Dallas; Menlo Park and San Francisco, CA; London, UK; Singapore; Sydney; and Beijing. Cambridge Associates consists of five global investment consulting affiliates that are all under common ownership and control. For more information about Cambridge Associates, please visit www.cambridgeassociates.com.
Press Release – San Francisco, CA (February 7, 2017) – Impact Community Capital (ICC) today announced that its Board of Directors has appointed Jeff Brenner as President and Chief Executive Officer. Mr. Brenner previously served as the firm’s interim President and CEO.
Established in 1998, ICC has provided more than $1 billion in financing for affordable multifamily housing, community healthcare facilities, childcare centers, and other community facilities serving families and communities in 38 states plus the District of Columbia. It was founded by a consortium of insurance companies to facilitate their investments in projects that benefit low-income families and communities.
“The Board is excited to have Jeff leading Impact as it implements its new, five-year growth strategy,” said Tony Tomich, ICC Board Chair. “During his time as interim CEO, Jeff has demonstrated the passion, commitment and leadership to achieve our vision of growing the company. We have every confidence Jeff will help ICC and its investors make large scale investments that will provide opportunities for low income communities and families.”
Mr. Brenner has built an impressive career in community development finance over the past 23 years. Prior to joining ICC, he served as CFO of Capital Impact Partners. During his tenure there, the firm was a leading innovator in building a bridge between the capital markets and investing in underserved communities. Mr. Brenner raised more than $600 million in new capital to finance facilities for housing, healthcare, education and fresh foods. He grew assets under management from $255 million to over $800 million. Since joining ICC in 2012, the firm has provided nearly $400 million of financing for affordable multifamily housing and securitized over $300 million dollars of mortgages in two securitizations consisting solely of loans for affordable housing projects.
“ICC is a true industry pioneer, and I am excited about the opportunity created by the growing interest in impact investing to reach new investors and to make investments that will help communities reach their economic and social potential,” said Mr. Brenner. “I’ve spent the past 30 years working to invest capital to improve the lives of people and communities and in doing so, demonstrating that these investments can be suitable for institutional investors seeking investment safety while making a significant impact in the communities they serve.”
About Impact Community Capital LLC
Impact Community Capital LLC is a for-profit company founded by leading insurers to promote socially responsible investments in underserved communities. The company was an early leader in making investments that facilitate social change long before “Impact Investing” began its move to the mainstream. Impact pioneered the pooling and securitization of community investment portfolios to direct large amounts of capital for affordable housing and used federal New Markets Tax Credits to invest in community childcare and healthcare facilities. It is owned by the following insurance companies: Allstate Insurance Company, Farmers Insurance Exchange, Nationwide Mutual Insurance Company, Pacific Life Insurance Company, State Farm Mutual Automobile Insurance Company, Teachers Insurance and Annuity Association of America, and 21st Century Insurance Company. For more information, call (415) 981-1074, or visit www.Impactcapital.net
Submit by February 10 for Chance to Win Early Entrant Prize
Press Release – ARLINGTON, VA (PRWEB) FEBRUARY 06, 2017: Solution Search is a global-crowdsourcing competition designed to spotlight the most promising approaches to conservation and development challenges. This year’s contest, Farming for Biodiversity, seeks entries showcasing innovative agriculture solutions that strengthen biodiversity and its benefits to food security, livelihoods and nutrition. This Friday, February 10, at 5 pm (ET) marks the Early Entry Deadline for organizations vying for a shot at the Solution Search Early Entry prize of $5,000. The final day to submit any entry for this year’s global crowd-sourcing competition is Friday, March 10, 2017, at 5 pm (ET). The early entrant winner will be selected by the Solution Search panel of judges during the three-month review session prior to the June 5th public voting kickoff, and announced at the Solution Search awards ceremony in September.
“The Early Entry Deadline is an excellent opportunity for entrants to showcase their solutions in advance and receive priority exposure in front of our panel of expert judges” said Brett Jenks, President and CEO of Rare.
The contest will run in direct partnership with IFOAM-Organics International, with additional partners Convention on Biological Diversity Secretariat, Save the Children, Blue Solutions, the Global Island Partnership and Panorama joining from across the globe. Solution Search also recently welcomed Patagonia, EcoAgriculture Partners, and Young Professionals for Agricultural Development (YPARD) as additional supporting partners in the contest. Most recently, the UN’s Indigenous Peoples’ rapporteur, Victoria Tauli-Corpuz, and Sarah Hayes, Patagonia’s Senior Manager of Materials, Innovation & Development have joined the contest’s prestigious judging panel.
Over the next couple of months, the Solution Search partners will be soliciting entries, working with expert judges to narrow the field and asking the public to weigh in and vote as well. In addition to two $30,000 grand prize awards, all entrants will be eligible for one of four side prizes of up to $15,000. All prize money must be used to further the winner’s solution and organization’s goals. Ten finalists will win a trip to New York City to attend a capacity-building workshop and awards ceremony alongside some of the biggest names in conservation and development. Following the contest’s conclusion, entrants will also be eligible to participate in a series of workshops and funding opportunities to help expand and apply their promising approaches around the world.
This contest is part of a larger project run in joint partnership by Rare and IFOAM-Organics International, and is funded by the International Climate Initiative (IKI), a German initiative supported by The Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB) on the basis of a decision adopted by the German Bundestag. The Convention on Biological Diversity (CBD) will offer additional support to the project by linking its findings and messages to global policy making. Over three years, the partners will work together to identify these promising approaches and then host capacity-building workshops across the globe to spread these effective solutions. This workshop series, known as Campaigning for Conservation, will aim to further empower local practitioners to raise awareness of the value of biodiversity and to conduct social marketing campaigns promoting behavior change in support of the identified solutions. All entries to this contest will become part of a larger network of stakeholders engaged in supporting biodiversity-friendly agriculture.
Visit solutionsearch.org to learn more, apply, or nominate a fellow organization for a chance to win a $1,000 nomination prize yourself.
Ranked in the top 25 NGOs in the world by NGO ADVISORS, Rare is an innovative conservation organization that implements proven conservation solutions and trains local leaders in communities worldwide. Through its signature social marketing campaigns (called Pride campaigns), Rare inspires people to take pride in the species and habitats that make their community unique, while also introducing practical alternatives to environmentally destructive practices. Employees of local governments or non-profit organizations receive extensive training on fisheries management, campaign planning and social marketing to communities. They are equipped to deliver community-based solutions based on natural and social science, while leveraging policy and market forces to accelerate positive environmental change through programs in clean water, sustainable agriculture, and coastal fisheries. To learn more about Rare, please visit http://www.rare.org.
ABOUT IFOAM-ORGANICS INTERNATIONAL
Since 1972, IFOAM – Organics International has occupied an unchallenged position as the only international umbrella organisation within the organic agriculture sector, uniting an enormous diversity of relevant stakeholders and key actors. IFOAM – Organics International implements the will of its broad-based constituency, close to 800 Affiliates in 125 countries, in a fair, inclusive and participatory manner.
IFOAM’s vision is worldwide adoption of ecologically, socially and economically sound agriculture systems, which will support the projects overarching goal to mainstream biodiversity into the agricultural sector. Through their extensive experience working with smallholder farmers, family farms and cooperatives in the sector, and by building local capacity through their Leadership Courses, IFOAM has the right knowledge, expertise, institutional structure and products to support the project.
The Convention on Biological Diversity (CBD) entered into force on 29 December 1993. It has 3 main objectives: The conservation of biological diversity. The sustainable use of the components of biological diversity. The fair and equitable sharing of the benefits arising out of the utilization of genetic resources.
The Convention was opened for signature on 5 June 1992 at the United Nations Conference on Environment and Development (the Rio “Earth Summit”). It remained open for signature until 4 June 1993, by which time it had received 168 signatures. The Convention entered into force on 29 December 1993.
It is the UN’s main body concerned with the conservation of biological diversity, the sustainable use of its components, and the fair and equitable sharing of benefits arising from the use of genetic resources.
Since 2008, the International Climate Initiative (IKI) of the Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB) has been financing climate and biodiversity projects in developing and newly industrialising countries, as well as in countries in transition. Based on a decision taken by the German parliament (Bundestag), a sum of at least 120 million euros is available for use by the initiative annually. For the first few years the IKI was financed through the auctioning of emission allowances, but it is now funded from the budget of the BMUB. The IKI is a key element of Germany’s climate financing and the funding commitments in the framework of the Convention on Biological Diversity.
The Initiative places clear emphasis on climate change mitigation, adaption to the impacts of climate change and the protection of biological diversity. These efforts provide various co-benefits, particularly the improvement of living conditions in partner countries. The IKI focuses on four areas: mitigating greenhouse gas emissions, adapting to the impacts of climate change, conserving natural carbon sinks with a focus on reducing emissions from deforestation and forest degradation (REDD+), as well as conserving biological diversity. New projects are primarily selected through a two-stage procedure that takes place once a year. Priority is given to activities that support creating an international climate protection architecture, to transparency, and to innovative and transferable solutions that have an impact beyond the individual project. The IKI cooperates closely with partner countries and supports consensus building for a comprehensive international climate agreement and the implementation of the Convention on Biological Diversity. Moreover, it is the goal of the IKI to create as many synergies as possible between climate protection and biodiversity conservation.